ARPO insider filings

Aerpio Pharmaceuticals, Inc. — 16 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-07-02. Screen ARPO transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ARPO between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Aerpio Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2021-07-024Dugel Pravin — DirectorGrant/award (A): 6,331 @ $1.52EDGAR
2021-07-024Cohen Cheryl — DirectorGrant/award (A): 8,140 @ $1.52EDGAR
2021-07-024Dalal Anupam — DirectorGrant/award (A): 7,400 @ $1.52EDGAR
2021-07-024Castelein Caley — DirectorGrant/award (A): 7,811 @ $1.52EDGAR
2021-07-024Prelack Steven — DirectorGrant/award (A): 12,334 @ $1.52EDGAR
2021-06-224Cohen Cheryl — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-04-024Cohen Cheryl — DirectorGrant/award (A): 8,020 @ $1.54EDGAR
2021-04-024Dalal Anupam — DirectorGrant/award (A): 7,290 @ $1.54EDGAR
2021-04-024Dugel Pravin — DirectorGrant/award (A): 6,237 @ $1.54EDGAR
2021-04-024Castelein Caley — DirectorGrant/award (A): 7,696 @ $1.54EDGAR
2021-04-024Prelack Steven — DirectorGrant/award (A): 12,151 @ $1.54EDGAR
2021-02-034Dugel Pravin — DirectorGrant/award (A): 17,857 (derivative) @ $0EDGAR
2021-02-034Cohen Cheryl — DirectorGrant/award (A): 17,857 (derivative) @ $0EDGAR
2021-02-034Dalal Anupam — DirectorGrant/award (A): 17,857 (derivative) @ $0EDGAR
2021-02-034Castelein Caley — DirectorGrant/award (A): 17,857 (derivative) @ $0EDGAR
2020-12-104ORBIMED ADVISORS LLC — 10% owner
OrbiMed Capital GP V LLC — 10% owner
Option exercise/expiry (X): 21,400 @ $0.96 · Sale (S): 21,400 @ $1.96 · Option exercise/expiry (X): 21,400 (derivative) @ $0EDGAR

Recent 8-K events — Aerpio Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-108-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-128-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-218-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-138-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ARPO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs